Chrome Extension
WeChat Mini Program
Use on ChatGLM

173 Patient Reported Outcomes Following EB-101 Treatment of Recessive Dystrophic Epidermolysis Bullosa (rdeb) Wounds Showed Durable Wound Healing and Reduction in Disease Burden

Journal of Investigative Dermatology(2021)SCI 1区

Stanford Univ | Abeona Therapeut Inc

Cited 0|Views34
Abstract
RDEB is an ultra-rare, severe, inherited collagen disorder caused by the absence of type VII collagen. Manifestations include fragility of stratified squamous epithelium, painful blistering, delayed or impaired wound healing, large, chronic severely painful wounds, increased risk of infection, malnutrition, invasive squamous cell carcinoma and premature mortality. We report long-term patient-reported outcomes following treatment of large, chronic RDEB wounds with the gene-corrected autologous cell therapy EB-101. Large RDEB wounds that remained unhealed for ≥12 weeks were treated with 35 cm2 gene-corrected keratinocyte sheets (EB-101). Up to 6 sheets were transplanted in each of 7 adult participants. 3 to 6 years after initial treatment, participants were asked to rate change in wound pain, for treated and control wounds, compared with their pre-treatment state using a seven-point scale, ranging from 1 (very much improved) to 7 (very much worse). Investigator assessment of wound healing data from the last visit was recorded for each responder. Responses were received from 5 participants with 27 treated chronic wounds and 5 chronic, untreated (control) wounds. 59% (16) of treated wounds had > 50% healing, of which 75% (12/16) had healing of > 75%. Compared to pre-treatment state, 67% (18/27) of treated wounds had improved pain (scores < 4), with much or very much improved pain (scores of 1-2) reported for treated wounds with > 50% healing (9/16, 56%). Pain improvement was not reported for control wounds, with 4/5 wounds having no change and 1/5 wounds having worse pain (score of 5). Four responders (4/5) reported willingness to undergo another EB-101 treatment, and 1 responder did not as he did not experience improvement. EB-101 treatment resulted in significant long-term wound healing and patient-reported reductions in wound-related pain in most treated large, chronic RDEB wounds.
More
Translated text
求助PDF
上传PDF
Bibtex
AI Read Science
AI Summary
AI Summary is the key point extracted automatically understanding the full text of the paper, including the background, methods, results, conclusions, icons and other key content, so that you can get the outline of the paper at a glance.
Example
Background
Key content
Introduction
Methods
Results
Related work
Fund
Key content
  • Pretraining has recently greatly promoted the development of natural language processing (NLP)
  • We show that M6 outperforms the baselines in multimodal downstream tasks, and the large M6 with 10 parameters can reach a better performance
  • We propose a method called M6 that is able to process information of multiple modalities and perform both single-modal and cross-modal understanding and generation
  • The model is scaled to large model with 10 billion parameters with sophisticated deployment, and the 10 -parameter M6-large is the largest pretrained model in Chinese
  • Experimental results show that our proposed M6 outperforms the baseline in a number of downstream tasks concerning both single modality and multiple modalities We will continue the pretraining of extremely large models by increasing data to explore the limit of its performance
Upload PDF to Generate Summary
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn
Chat Paper

要点】:该研究报道了使用基因矫正的自体细胞疗法EB-101治疗大范围慢性RDEB伤口后,患者报告的长期疗效显示伤口愈合持久且疾病负担减轻。

方法】:研究采用35 cm²基因矫正的角质细胞片(EB-101)治疗持续未愈合12周以上的大面积RDEB伤口。

实验】:7名成年参与者接受了最多6片的治疗,3至6年后,参与者使用7点量表评价治疗前后伤口疼痛的变化。5名参与者反馈了27个已治疗的慢性伤口和5个未治疗的慢性伤口的数据,结果显示59%的治疗伤口愈合超过50%,67%的治疗伤口疼痛有所改善,而控制组伤口疼痛无改善。